acetaminophen has been researched along with Diseases of Endocrine System in 1 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Ruffolo, LI | 1 |
Jackson, KM | 1 |
Juviler, P | 1 |
Kaur, R | 1 |
Chennell, T | 1 |
Glover, DM | 1 |
Linehan, DC | 1 |
Moalem, J | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Controlled Trial for Postoperative opt-in Narcotic Treatment in Outpatient Endocrine Surgery[NCT04710069] | 102 participants (Actual) | Interventional | 2020-06-26 | Completed | |||
Optimization of Opioid Discharge Prescriptions Following Thyroid and Parathyroid Surgeries[NCT04955444] | 240 participants (Actual) | Interventional | 2021-06-14 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Proportion of patients who receive new opioid discharge prescriptions at discharge following a thyroidectomy or parathyroidectomy procedure. This outcome excludes continuation of previous, chronic opioid therapy. (NCT04955444)
Timeframe: Up to 2 days
Intervention | Participants (Count of Participants) |
---|---|
Historical Control Group | 128 |
Post-implementation Group | 28 |
Proportion of thyroidectomy and parathyroidectomy postoperative patients who receive new opioid prescriptions from the surgeon's office within 7 days of surgery including discharge prescriptions. This outcome excludes continuation of previous, chronic opioid therapy. (NCT04955444)
Timeframe: Up to 7 days
Intervention | Participants (Count of Participants) |
---|---|
Historical Control Group | 0 |
Post-implementation Group | 0 |
Proportion of thyroidectomy and parathyroidectomy postoperative patients with opioid discharge prescriptions exceeding the recommended dose of 112.5 oral MMEs (NCT04955444)
Timeframe: Up to 2 days
Intervention | Participants (Count of Participants) |
---|---|
Historical Control Group | 52 |
Post-implementation Group | 8 |
Proportion of thyroidectomy and parathyroidectomy postoperative patients with opioid discharge prescriptions exceeding 5 days of therapy (NCT04955444)
Timeframe: Up to 2 days
Intervention | Participants (Count of Participants) |
---|---|
Historical Control Group | 27 |
Post-implementation Group | 5 |
Proportion of thyroidectomy and parathyroidectomy postoperative patients with opioid prescriptions exceeding 50 oral MMEs/day when new, postoperative discharge prescriptions are added to existing opioid therapy (NCT04955444)
Timeframe: Up to 2 days
Intervention | Participants (Count of Participants) |
---|---|
Historical Control Group | 9 |
Post-implementation Group | 0 |
1 other study available for acetaminophen and Diseases of Endocrine System
Article | Year |
---|---|
Narcotic Free Cervical Endocrine Surgery: A Shift in Paradigm.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesics, Opioid; Endocrine System Diseases; Female | 2021 |
Narcotic Free Cervical Endocrine Surgery: A Shift in Paradigm.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesics, Opioid; Endocrine System Diseases; Female | 2021 |
Narcotic Free Cervical Endocrine Surgery: A Shift in Paradigm.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesics, Opioid; Endocrine System Diseases; Female | 2021 |
Narcotic Free Cervical Endocrine Surgery: A Shift in Paradigm.
Topics: Acetaminophen; Ambulatory Surgical Procedures; Analgesics, Opioid; Endocrine System Diseases; Female | 2021 |